H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 74 Citations 21,336 218 World Ranking 858 National Ranking 477
Medicine D-index 99 Citations 37,825 400 World Ranking 3918 National Ranking 2216

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Gene

Daniel R. Kuritzkes spends much of his time researching Immunology, Virology, Drug resistance, Acquired immunodeficiency syndrome and Internal medicine. Specifically, his work in Virology is concerned with the study of Zidovudine. His Drug resistance study combines topics in areas such as Reverse transcriptase, Bioinformatics, Regimen, Genotype and Drug.

His work in Acquired immunodeficiency syndrome addresses subjects such as Intensive care medicine, which are connected to disciplines such as Clinical research. Daniel R. Kuritzkes has researched Internal medicine in several fields, including Efavirenz, Oncology and Reverse-transcriptase inhibitor. His Viral load research is multidisciplinary, relying on both Viremia and Antibody.

His most cited work include:

  • Update of the Drug Resistance Mutations in HIV-1. (1203 citations)
  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation (910 citations)
  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. (775 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Virology, Immunology, Viral load, Virus and Internal medicine. The Virology study combines topics in areas such as Mutation, Reverse transcriptase and Drug resistance. In his research on the topic of Immunology, Clinical trial and Intensive care medicine is strongly related with Acquired immunodeficiency syndrome.

His study focuses on the intersection of Viral load and fields such as Ritonavir with connections in the field of Lopinavir. His Virus research incorporates themes from RNA and CCR5 receptor antagonist. The various areas that Daniel R. Kuritzkes examines in his Internal medicine study include Gastroenterology, Efavirenz, Oncology and Reverse-transcriptase inhibitor.

He most often published in these fields:

  • Virology (47.25%)
  • Immunology (41.95%)
  • Viral load (24.15%)

What were the highlights of his more recent work (between 2015-2021)?

  • Immunology (41.95%)
  • Viral load (24.15%)
  • Virology (47.25%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, Viral load, Virology, Antiretroviral therapy and Immune system. His Immunology research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation, Clinical trial, Acquired immunodeficiency syndrome and Cohort. The concepts of his Viral load study are interwoven with issues in Viremia, Internal medicine, Lymphocyte, Viral rebound and Viral replication.

Particularly relevant to Lentivirus is his body of work in Virology. His studies in Antiretroviral therapy integrate themes in fields like MEDLINE and Intensive care medicine. His Immune system study incorporates themes from Virus, Lymphatic system and Antibody.

Between 2015 and 2021, his most popular works were:

  • International AIDS Society global scientific strategy: towards an HIV cure 2016 (268 citations)
  • HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study (121 citations)
  • HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study (121 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Virus

Daniel R. Kuritzkes mostly deals with Viral load, Immunology, Virology, RNA and Antiretroviral therapy. His work deals with themes such as Preventive healthcare, Viremia, Integrase inhibitor, Internal medicine and Viral replication, which intersect with Viral load. His study in Immune system and Virus falls within the category of Immunology.

His Virology research integrates issues from Cell and Motion sensing. Daniel R. Kuritzkes combines subjects such as Autologous transplantation, Stem cell and Intensive care medicine with his study of Antiretroviral therapy. His Lamivudine study combines topics from a wide range of disciplines, such as Reverse transcriptase, Drug development and Zidovudine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Update of the Drug Resistance Mutations in HIV-1.

Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2008)

1940 Citations

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

Pereyra F;Jia X;McLaren Pj.
Science (2010)

1350 Citations

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner.
The New England Journal of Medicine (2003)

1133 Citations

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes.
PLOS ONE (2009)

992 Citations

Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

Martin S. Hirsch;Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer.
JAMA (2000)

818 Citations

HIV viral load markers in clinical practice

M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien.
Nature Medicine (1996)

740 Citations

Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

Martin S. Hirsch;Brian Conway;Richard T. D'Aquila;Victoria A. Johnson.
JAMA (1998)

718 Citations

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten.
The New England Journal of Medicine (2004)

694 Citations

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway.
Clinical Infectious Diseases (2003)

668 Citations

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Françoise Brun Vézinet.
Clinical Infectious Diseases (2008)

622 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Daniel R. Kuritzkes

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 183

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 169

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 157

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 148

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 130

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 126

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 123

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 121

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 115

Deenan Pillay

Deenan Pillay

University College London

Publications: 110

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 109

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 106

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 106

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 104

P. Richard Harrigan

P. Richard Harrigan

University of British Columbia

Publications: 97

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 96

Something went wrong. Please try again later.